메뉴 건너뛰기




Volumn 50, Issue 10, 2010, Pages 22-26

The efficacy and safety of the combination of β-blocker bisoprolol and If inhibitor ivabradine in patients with stable angina and chronic obstructive pulmonary disease

Author keywords

Angina pectoris; Bisoprolol; Chronic obstructive pulmonary disease; Ivabradine

Indexed keywords

BENZAZEPINE DERIVATIVE; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BRONCHODILATING AGENT; CYCLIC NUCLEOTIDE GATED CHANNEL; IVABRADINE;

EID: 79955097006     PISSN: 00229040     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (5)

References (8)
  • 1
  • 3
    • 0026877917 scopus 로고
    • The MOS 36-item short-form health survey
    • Ware J.E., Sheiboume C.D. The MOS 36-Item short-form health survey. Med Care 1992;30:6:473-483.
    • (1992) Med Care , vol.30 , Issue.6 , pp. 473-483
    • Ware, J.E.1    Sheiboume, C.D.2
  • 4
    • 50649089781 scopus 로고    scopus 로고
    • Heart rate as a prognostic risk factor in the patients with coronary artery disease and left-ventricular systolic disfunction (BEAUTIFUL): A subgroup analysis of a randomized controlled trial
    • on behalf of the the BEAUTIFUL investigators
    • Fox K. et al. on behalf of the the BEAUTIFUL investigators. Heart rate as a prognostic risk factor in the patients with coronary artery disease and left-ventricular systolic disfunction (BEAUTIFUL): a subgroup analysis of a randomized controlled trial. Lancet 2008; 372:817-821.
    • (2008) Lancet , vol.372 , pp. 817-821
    • Fox, K.1
  • 5
    • 50649109186 scopus 로고    scopus 로고
    • Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): A randomized, double-blind, placebo-controlled trial
    • on behalf of the the BEAUTIFUL investigators
    • Fox K. et al. on behalf of the the BEAUTIFUL investigators. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomized, double-blind, placebo-controlled trial. Lancet 2008; 372:807-816.
    • (2008) Lancet , vol.372 , pp. 807-816
    • Fox, K.1
  • 6
    • 63349103473 scopus 로고    scopus 로고
    • Efficacy of the I, current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: A 4 month, randomized, placebo-controlled trial
    • for the ASSOCIATE study Investigators doi:10.1093/eurheartj/ehn571
    • Tardif J.-C. et al. for the ASSOCIATE study Investigators. Efficacy of the I, current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4 month, randomized, placebo-controlled trial. Eur Heat J 2009. doi:10.1093/eurheartj/ehn571.
    • (2009) Eur Heat J
    • Tardif, J.-C.1
  • 7
    • 84876969135 scopus 로고    scopus 로고
    • Beta-1-selective beta-blockers safer for heart failure patients with COPD
    • Hayward C.S. et al. Beta-1-Selective Beta-Blockers Safer for Heart Failure Patients With COPD. J Am Coll Cardiol 2010;55:1780-1787.
    • (2010) J Am Coll Cardiol , vol.55 , pp. 1780-1787
    • Hayward, C.S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.